SCHEMBL8036828

SCHEMBL8036828

CCOC(=O)c1c(CC)nc(-c2ccc(C)cc2)nc1N(CC)CC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 4/20 0.44
ALDH1A1 P00352 6/20 0.43
MAPT P10636 3/20 0.43
PKM P14618 2/20 0.43
KDM4E B2RXH2 3/20 0.43
RAB9A P51151 2/20 0.43
TP53 P04637 1/20 0.43
HSD17B10 Q99714 1/20 0.43
TARBP2 Q15633 1/20 0.41
TRPM8 Q7Z2W7 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.40
GABRA2 P47869 1/20 0.40
GABRB2 P47870 1/20 0.40
TSHR P16473 2/20 0.40
LMNA P02545 2/20 0.40
HTT P42858 2/20 0.40
NPC1 O15118 2/20 0.39
GAA P10253 2/20 0.39
POLB P06746 1/20 0.39
MEN1 O00255 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8037266 0.91 GABRA2 (0.45) ADORA3ALDH1A1MAPTPKMKDM4E
SCHEMBL4009387 0.86 DPP4 (0.44) ADORA3ALDH1A1MAPTKDM4ETP53
SCHEMBL4009335 0.82 ALDH1A1 (0.38) ADORA3ALDH1A1MAPTPKMKDM4E
SCHEMBL8040651 0.81 ADORA3 (0.47) ADORA3ALDH1A1MAPTPKMKDM4E
SCHEMBL4009391 0.79 ALDH1A1 (0.41) ADORA3ALDH1A1MAPTPKMKDM4E
SCHEMBL8040514 0.78 KDM4E (0.51) ALDH1A1MAPTPKMKDM4ERAB9A
SCHEMBL12929596 0.77 ALDH1A1 (0.65) ALDH1A1MAPTPKMRAB9ATP53
SCHEMBL12929410 0.77 ADORA3 (0.57) ADORA3ALDH1A1MAPTKDM4ERAB9A
SCHEMBL8042776 0.76 TSHR (0.48) ADORA3ALDH1A1MAPTPKMKDM4E
SCHEMBL8025238 0.75 RXRA (0.48) ADORA3ALDH1A1MAPTPKMKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009080242-A1 SUBSTITUTED 4-AMINOPYRIMIDINE-5-CARBOXYLIC ACID AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2009-07-02 WO disclosed